{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:51:48Z","timestamp":1790707908762,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["634413"],"award-info":[{"award-number":["634413"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["722619"],"award-info":[{"award-number":["722619"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P26766"],"award-info":[{"award-number":["P26766"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatic steatosis develops when lipid influx and production exceed the liver\u2019s ability to utilize\/export triglycerides. Obesity promotes steatosis and is characterized by leptin resistance. A role of leptin in hepatic lipid handling is highlighted by the observation that recombinant leptin reverses steatosis of hypoleptinemic patients with lipodystrophy by an unknown mechanism. Since leptin mainly functions via CNS signaling, we here examine in rats whether leptin regulates hepatic lipid flux via the brain in a series of stereotaxic infusion experiments. We demonstrate that brain leptin protects from steatosis by promoting hepatic triglyceride export and decreasing de novo lipogenesis independently of caloric intake. Leptin\u2019s anti-steatotic effects are generated in the dorsal vagal complex, require hepatic vagal innervation, and are preserved in high-fat-diet-fed rats when the blood brain barrier is bypassed. Thus, CNS leptin protects from ectopic lipid accumulation via a brain-vagus-liver axis and may be a therapeutic strategy to ameliorate obesity-related steatosis.<\/jats:p>","DOI":"10.1038\/s41467-019-10684-1","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T06:02:54Z","timestamp":1561010574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3182-788X","authenticated-orcid":false,"given":"Martina Theresa","family":"Hackl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"F\u00fcrnsinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0089-5989","authenticated-orcid":false,"given":"Christina Maria","family":"Schuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9717-803X","authenticated-orcid":false,"given":"Martin","family":"Krssak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Freudenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Baumgartner-Parzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3169-778X","authenticated-orcid":false,"given":"Thomas H.","family":"Helbich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5000-1974","authenticated-orcid":false,"given":"Maximilian","family":"Zeyda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2594-1651","authenticated-orcid":false,"given":"Amalia","family":"Gastaldelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Buettner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4980-706X","authenticated-orcid":false,"given":"Thomas","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"10684_CR1","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/ajg.2012.314","volume":"107","author":"YM Kwon","year":"2012","unstructured":"Kwon, Y. M. et al. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am. J. Gastroenterol. 107, 1852\u20131858 (2012).","journal-title":"Am. J. Gastroenterol."},{"key":"10684_CR2","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1172\/JCI6576","volume":"103","author":"M Raabe","year":"1999","unstructured":"Raabe, M. et al. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J. Clin. Invest. 103, 1287\u20131298 (1999).","journal-title":"J. Clin. Invest."},{"key":"10684_CR3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1146\/annurev.nutr.20.1.663","volume":"20","author":"N Berriot-Varoqueaux","year":"2000","unstructured":"Berriot-Varoqueaux, N., Aggerbeck, L. P., Samson-Bouma, M. & Wetterau, J. R. The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu Rev. Nutr. 20, 663\u2013697 (2000).","journal-title":"Annu Rev. Nutr."},{"key":"10684_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1056\/NEJMoa061189","volume":"356","author":"M Cuchel","year":"2007","unstructured":"Cuchel, M. et al. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N. Engl. J. Med. 356, 148\u2013156 (2007).","journal-title":"N. Engl. J. Med."},{"key":"10684_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1194\/jlr.M200342-JLR200","volume":"44","author":"G Schonfeld","year":"2003","unstructured":"Schonfeld, G. et al. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis. J. Lipid Res. 44, 470\u2013478 (2003).","journal-title":"J. Lipid Res."},{"key":"10684_CR6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1194\/jlr.M002915","volume":"51","author":"ME Visser","year":"2010","unstructured":"Visser, M. E. et al. Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia. J. Lipid Res. 51, 1057\u20131062 (2010).","journal-title":"J. Lipid Res."},{"key":"10684_CR7","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1056\/NEJMra025261","volume":"350","author":"A Garg","year":"2004","unstructured":"Garg, A. Acquired and inherited lipodystrophies. N. Engl. J. Med. 350, 1220\u20131234 (2004).","journal-title":"N. Engl. J. Med."},{"key":"10684_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1172\/JCI0215001","volume":"109","author":"KF Petersen","year":"2002","unstructured":"Petersen, K. F. et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J. Clin. Invest. 109, 1345\u20131350 (2002).","journal-title":"J. Clin. Invest."},{"key":"10684_CR9","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1056\/NEJMoa012437","volume":"346","author":"EA Oral","year":"2002","unstructured":"Oral, E. A. et al. Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med. 346, 570\u2013578 (2002).","journal-title":"N. Engl. J. Med."},{"key":"10684_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1096\/fj.06-6557com","volume":"21","author":"S Fishman","year":"2007","unstructured":"Fishman, S. et al. Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo. FASEB J. 21, 53\u201360 (2007).","journal-title":"FASEB J."},{"key":"10684_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.metabol.2003.10.019","volume":"53","author":"SA Moran","year":"2004","unstructured":"Moran, S. A. et al. Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy. Metabolism 53, 513\u2013519 (2004).","journal-title":"Metabolism"},{"key":"10684_CR12","doi-asserted-by":"crossref","unstructured":"Brown, R. J. et al Metreleptin improves insulin sensitivity independent of food intake in humans with lipodystrophy. J. Clin. Invest. 128, 3504\u20133516 (2018).","DOI":"10.1172\/JCI95476"},{"key":"10684_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","volume":"134","author":"E Fabbrini","year":"2008","unstructured":"Fabbrini, E. et al. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134, 424\u2013431 (2008).","journal-title":"Gastroenterology"},{"key":"10684_CR14","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2337\/db11-1142","volume":"61","author":"E Bruinstroop","year":"2012","unstructured":"Bruinstroop, E. et al. Hypothalamic neuropeptide Y (NPY) controls hepatic VLDL-triglyceride secretion in rats via the sympathetic nervous system. Diabetes 61, 1043\u20131050 (2012).","journal-title":"Diabetes"},{"key":"10684_CR15","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.2337\/db07-1702","volume":"57","author":"JM Stafford","year":"2008","unstructured":"Stafford, J. M. et al. Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion. Diabetes 57, 1482\u20131490 (2008).","journal-title":"Diabetes"},{"key":"10684_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nm1540","volume":"13","author":"TK Lam","year":"2007","unstructured":"Lam, T. K. et al. Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat. Med. 13, 171\u2013180 (2007).","journal-title":"Nat. Med."},{"key":"10684_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6970","volume":"6","author":"JT Yue","year":"2015","unstructured":"Yue, J. T. et al. A fatty acid-dependent hypothalamic-DVC neurocircuitry that regulates hepatic secretion of triglyceride-rich lipoproteins. Nat. Commun. 6, 5970, https:\/\/doi.org\/10.1038\/ncomms6970 (2015).","journal-title":"Nat. Commun."},{"key":"10684_CR18","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.2337\/diabetes.53.10.2529","volume":"53","author":"AM van den Hoek","year":"2004","unstructured":"van den Hoek, A. M. et al. Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin. Diabetes 53, 2529\u20132534 (2004).","journal-title":"Diabetes"},{"key":"10684_CR19","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.2337\/db15-1552","volume":"65","author":"T Scherer","year":"2016","unstructured":"Scherer, T. et al. Insulin regulates hepatic triglyceride secretion and lipid content via signaling in the brain. Diabetes 65, 1511\u20131520 (2016).","journal-title":"Diabetes"},{"key":"10684_CR20","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1161\/01.ATV.17.7.1454","volume":"17","author":"R Malmstrom","year":"1997","unstructured":"Malmstrom, R. et al. Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler. Thromb. Vasc. Biol. 17, 1454\u20131464 (1997).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10684_CR21","first-page":"2347","volume":"118","author":"A Kamagate","year":"2008","unstructured":"Kamagate, A. et al. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J. Clin. Invest. 118, 2347\u20132364 (2008).","journal-title":"J. Clin. Invest."},{"key":"10684_CR22","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.2337\/diabetes.51.10.3025","volume":"51","author":"C Anderwald","year":"2002","unstructured":"Anderwald, C. et al. Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 51, 3025\u20133032 (2002).","journal-title":"Diabetes"},{"issue":"6","key":"10684_CR23","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.2337\/db14-0892","volume":"64","author":"Sofiya Gancheva","year":"2015","unstructured":"Gancheva, S. et al. Effects of intranasal insulin on hepatic fat accumulation and energy metabolism in humans. Diabetes 64, 1966\u20131975 (2015).","journal-title":"Diabetes"},{"key":"10684_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2337\/dc15-1531","volume":"39","author":"JB Buse","year":"2016","unstructured":"Buse, J. B. et al. Randomized clinical trial comparing basal insulin peglispro and insulin glargine in patients with type 2 diabetes previously treated with basal insulin: IMAGINE 5. Diabetes Care 39, 92\u2013100 (2016).","journal-title":"Diabetes Care"},{"key":"10684_CR25","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1172\/JCI24059","volume":"115","author":"C de Luca","year":"2005","unstructured":"de Luca, C. et al. Complete rescue of obesity, diabetes, and infertility in db\/db mice by neuron-specific LEPR-B transgenes. J. Clin. Invest. 115, 3484\u20133493 (2005).","journal-title":"J. Clin. Invest."},{"key":"10684_CR26","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1210\/en.2007-0261","volume":"148","author":"K Guo","year":"2007","unstructured":"Guo, K. et al. Disruption of peripheral leptin signaling in mice results in hyperleptinemia without associated metabolic abnormalities. Endocrinology 148, 3987\u20133997 (2007).","journal-title":"Endocrinology"},{"key":"10684_CR27","doi-asserted-by":"publisher","first-page":"13100","DOI":"10.1073\/pnas.0903723106","volume":"106","author":"A Singh","year":"2009","unstructured":"Singh, A. et al. Leptin-mediated changes in hepatic mitochondrial metabolism, structure, and protein levels. Proc. Natl Acad. Sci. USA 106, 13100\u201313105 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10684_CR28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1172\/JCI200113914","volume":"108","author":"P Cohen","year":"2001","unstructured":"Cohen, P. et al. Selective deletion of leptin receptor in neurons leads to obesity. J. Clin. Invest. 108, 1113\u20131121 (2001).","journal-title":"J. Clin. Invest."},{"key":"10684_CR29","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","volume":"282","author":"SB Heymsfield","year":"1999","unstructured":"Heymsfield, S. B. et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282, 1568\u20131575 (1999).","journal-title":"JAMA"},{"key":"10684_CR30","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2337\/db10-1791","volume":"60","author":"HS Moon","year":"2011","unstructured":"Moon, H. S. et al. Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance. Diabetes 60, 1647\u20131656 (2011).","journal-title":"Diabetes"},{"key":"10684_CR31","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0196-9781(99)00139-4","volume":"20","author":"WA Banks","year":"1999","unstructured":"Banks, W. A., DiPalma, C. R. & Farrell, C. L. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 20, 1341\u20131345 (1999).","journal-title":"Peptides"},{"key":"10684_CR32","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2337\/diabetes.49.7.1219","volume":"49","author":"B Burguera","year":"2000","unstructured":"Burguera, B. et al. Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes 49, 1219\u20131223 (2000).","journal-title":"Diabetes"},{"key":"10684_CR33","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1172\/JCI9842","volume":"105","author":"K El-Haschimi","year":"2000","unstructured":"El-Haschimi, K., Pierroz, D. D., Hileman, S. M., Bjorbaek, C. & Flier, J. S. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J. Clin. Invest. 105, 1827\u20131832 (2000).","journal-title":"J. Clin. Invest."},{"key":"10684_CR34","doi-asserted-by":"publisher","first-page":"8878","DOI":"10.1073\/pnas.94.16.8878","volume":"94","author":"JL Halaas","year":"1997","unstructured":"Halaas, J. L. et al. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl Acad. Sci. USA 94, 8878\u20138883 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10684_CR35","doi-asserted-by":"publisher","first-page":"12189","DOI":"10.1523\/JNEUROSCI.2336-11.2011","volume":"31","author":"PJ Enriori","year":"2011","unstructured":"Enriori, P. J., Sinnayah, P., Simonds, S. E., Garcia Rudaz, C. & Cowley, M. A. Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance. J. Neurosci. 31, 12189\u201312197 (2011).","journal-title":"J. Neurosci."},{"key":"10684_CR36","doi-asserted-by":"publisher","first-page":"R868","DOI":"10.1152\/ajpregu.00213.2006","volume":"292","author":"J Zhang","year":"2007","unstructured":"Zhang, J., Matheny, M. K., Tumer, N., Mitchell, M. K. & Scarpace, P. J. Leptin antagonist reveals that the normalization of caloric intake and the thermic effect of food after high-fat feeding are leptin dependent. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R868\u2013R874 (2007).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10684_CR37","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.1073\/pnas.93.13.6231","volume":"93","author":"N Ghilardi","year":"1996","unstructured":"Ghilardi, N. et al. Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl Acad. Sci. USA 93, 6231\u20136235 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10684_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0014-5793(96)00790-9","volume":"392","author":"MY Wang","year":"1996","unstructured":"Wang, M. Y., Zhou, Y. T., Newgard, C. B. & Unger, R. H. A novel leptin receptor isoform in rat. FEBS Lett. 392, 87\u201390 (1996).","journal-title":"FEBS Lett."},{"key":"10684_CR39","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1194\/jlr.M200189-JLR200","volume":"43","author":"AD Attie","year":"2002","unstructured":"Attie, A. D. et al. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J. Lipid Res. 43, 1899\u20131907 (2002).","journal-title":"J. Lipid Res."},{"key":"10684_CR40","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1172\/JCI200419511","volume":"113","author":"E Asilmaz","year":"2004","unstructured":"Asilmaz, E. et al. Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J. Clin. Invest. 113, 414\u2013424 (2004).","journal-title":"J. Clin. Invest."},{"key":"10684_CR41","doi-asserted-by":"crossref","unstructured":"Bruinstroop, E. et al. Hypothalamic neuropeptide (NPY) controls hepatic vldl-triglyceride secretion in rats via the sympathetic nervous system Diabetes 61, 1043\u20131050 (2012).","DOI":"10.2337\/db11-1142"},{"key":"10684_CR42","first-page":"G781","volume":"259","author":"G Cucchiaro","year":"1990","unstructured":"Cucchiaro, G. et al. Evaluation of selective liver denervation methods. Am. J. Physiol. 259, G781\u2013G785 (1990).","journal-title":"Am. J. Physiol."},{"key":"10684_CR43","first-page":"562","volume":"198","author":"WW Lautt","year":"1976","unstructured":"Lautt, W. W. & Cote, M. G. Functional evaluation of 6-hydroxydopamine-induced sympathectomy in the liver of the cat. J. Pharm. Exp. Ther. 198, 562\u2013567 (1976).","journal-title":"J. Pharm. Exp. Ther."},{"key":"10684_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2006.04.014","volume":"4","author":"C Buettner","year":"2006","unstructured":"Buettner, C. et al. Critical role of STAT3 in leptin\u2019s metabolic actions. Cell Metab. 4, 49\u201360 (2006).","journal-title":"Cell Metab."},{"key":"10684_CR45","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nm1775","volume":"14","author":"C Buettner","year":"2008","unstructured":"Buettner, C. et al. Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat. Med. 14, 667\u2013675 (2008).","journal-title":"Nat. Med."},{"key":"10684_CR46","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.2337\/db10-1302","volume":"60","author":"B Mittendorfer","year":"2011","unstructured":"Mittendorfer, B. et al. Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes. Diabetes 60, 1474\u20131477 (2011).","journal-title":"Diabetes"},{"key":"10684_CR47","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1600-0676.1998.tb00817.x","volume":"18","author":"H Akiyoshi","year":"1998","unstructured":"Akiyoshi, H., Gonda, T. & Terada, T. A comparative histochemical and immunohistochemical study of aminergic, cholinergic and peptidergic innervation in rat, hamster, guinea pig, dog and human livers. Liver 18, 352\u2013359 (1998).","journal-title":"Liver"},{"key":"10684_CR48","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/cphy.c120018","volume":"3","author":"KJ Jensen","year":"2013","unstructured":"Jensen, K. J., Alpini, G. & Glaser, S. Hepatic nervous system and neurobiology of the liver. Compr. Physiol. 3, 655\u2013665 (2013).","journal-title":"Compr. Physiol."},{"key":"10684_CR49","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1053\/jhep.2000.18712","volume":"32","author":"M Roden","year":"2000","unstructured":"Roden, M., Anderwald, C., Furnsinn, C., Waldhausl, W. & Lohninger, A. Effects of short-term leptin exposure on triglyceride deposition in rat liver. Hepatology 32, 1045\u20131049 (2000).","journal-title":"Hepatology"},{"key":"10684_CR50","doi-asserted-by":"publisher","first-page":"21695","DOI":"10.1074\/jbc.M401546200","volume":"279","author":"W Huang","year":"2004","unstructured":"Huang, W., Dedousis, N., Bhatt, B. A. & O\u2019Doherty, R. M. Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity. J. Biol. Chem. 279, 21695\u201321700 (2004).","journal-title":"J. Biol. Chem."},{"key":"10684_CR51","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/sj.ijo.0800648","volume":"22","author":"J Dallongeville","year":"1998","unstructured":"Dallongeville, J. et al. Short term response of circulating leptin to feeding and fasting in man: influence of circadian cycle. Int J. Obes. Relat. Metab. Disord. 22, 728\u2013733 (1998).","journal-title":"Int J. Obes. Relat. Metab. Disord."},{"key":"10684_CR52","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1210\/jcem.83.6.4864","volume":"83","author":"C Simon","year":"1998","unstructured":"Simon, C., Gronfier, C., Schlienger, J. L. & Brandenberger, G. Circadian and ultradian variations of leptin in normal man under continuous enteral nutrition: relationship to sleep and body temperature. J. Clin. Endocrinol. Metab. 83, 1893\u20131899 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10684_CR53","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/415339a","volume":"415","author":"Y Minokoshi","year":"2002","unstructured":"Minokoshi, Y. et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339\u2013343 (2002).","journal-title":"Nature"},{"key":"10684_CR54","doi-asserted-by":"publisher","first-page":"11848","DOI":"10.1073\/pnas.182420899","volume":"99","author":"Y Lee","year":"2002","unstructured":"Lee, Y. et al. PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue. Proc. Natl Acad. Sci. USA 99, 11848\u201311853 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10684_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","volume":"7","author":"TR Koves","year":"2008","unstructured":"Koves, T. R. et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7, 45\u201356 (2008).","journal-title":"Cell Metab."},{"key":"10684_CR56","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1172\/JCI88477","volume":"127","author":"RJ Perry","year":"2017","unstructured":"Perry, R. J. et al. Mechanism for leptin\u2019s acute insulin-independent effect to reverse diabetic ketoacidosis. J. Clin. Invest. 127, 657\u2013669 (2017).","journal-title":"J. Clin. Invest."},{"key":"10684_CR57","doi-asserted-by":"publisher","first-page":"5604","DOI":"10.1210\/en.2007-0933","volume":"148","author":"N Gallardo","year":"2007","unstructured":"Gallardo, N. et al. Tissue-specific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue. Endocrinology 148, 5604\u20135610 (2007).","journal-title":"Endocrinology"},{"key":"10684_CR58","doi-asserted-by":"publisher","first-page":"14795","DOI":"10.1073\/pnas.93.25.14795","volume":"93","author":"G Chen","year":"1996","unstructured":"Chen, G. et al. Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc. Natl Acad. Sci. USA 93, 14795\u201314799 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10684_CR59","doi-asserted-by":"crossref","unstructured":"Cernea, S., Roiban, A. L., Both, E. & Hutanu, A. Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes. Diabetes Metab. Res. Rev. 34, e3050 (2018).","DOI":"10.1002\/dmrr.3050"},{"key":"10684_CR60","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00125-015-3769-3","volume":"59","author":"SA Polyzos","year":"2016","unstructured":"Polyzos, S. A. et al. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Diabetologia 59, 30\u201343 (2016).","journal-title":"Diabetologia"},{"key":"10684_CR61","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0196-9781(96)00025-3","volume":"17","author":"WA Banks","year":"1996","unstructured":"Banks, W. A., Kastin, A. J., Huang, W., Jaspan, J. B. & Maness, L. M. Leptin enters the brain by a saturable system independent of insulin. Peptides 17, 305\u2013311 (1996).","journal-title":"Peptides"},{"key":"10684_CR62","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1210\/en.2011-1586","volume":"153","author":"C Schulz","year":"2012","unstructured":"Schulz, C., Paulus, K., Johren, O. & Lehnert, H. Intranasal leptin reduces appetite and induces weight loss in rats with diet-induced obesity (DIO). Endocrinology 153, 143\u2013153 (2012).","journal-title":"Endocrinology"},{"key":"10684_CR63","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1210\/en.2005-1016","volume":"147","author":"S Fliedner","year":"2006","unstructured":"Fliedner, S., Schulz, C. & Lehnert, H. Brain uptake of intranasally applied radioiodinated leptin in Wistar rats. Endocrinology 147, 2088\u20132094 (2006).","journal-title":"Endocrinology"},{"key":"10684_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2014.05.044","volume":"191","author":"X Yi","year":"2014","unstructured":"Yi, X. et al. Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity. J. Control. Release 191, 34\u201346 (2014).","journal-title":"J. Control. Release"},{"key":"10684_CR65","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1124\/jpet.109.158147","volume":"333","author":"TO Price","year":"2010","unstructured":"Price, T. O. et al. Transport across the blood-brain barrier of pluronic leptin. J. Pharm. Exp. Ther. 333, 253\u2013263 (2010).","journal-title":"J. Pharm. Exp. Ther."},{"key":"10684_CR66","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2337\/db13-1609","volume":"63","author":"C Clemmensen","year":"2014","unstructured":"Clemmensen, C. et al. GLP-1\/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet. Diabetes 63, 1422\u20131427 (2014).","journal-title":"Diabetes"},{"key":"10684_CR67","first-page":"E321","volume":"274","author":"F Diraison","year":"1998","unstructured":"Diraison, F. & Beylot, M. Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification. Am. J. Physiol. 274, E321\u2013E327 (1998).","journal-title":"Am. J. Physiol."},{"key":"10684_CR68","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm1201","volume":"11","author":"TK Lam","year":"2005","unstructured":"Lam, T. K. et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat. Med. 11, 320\u2013327 (2005).","journal-title":"Nat. Med."},{"key":"10684_CR69","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2011.01.008","volume":"13","author":"T Scherer","year":"2011","unstructured":"Scherer, T. et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab. 13, 183\u2013194 (2011).","journal-title":"Cell Metab."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10684-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10684-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10684-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T18:56:45Z","timestamp":1671217005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10684-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["10684"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-10684-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"assertion":[{"value":"7 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2717"}}